Semaglutide has emerged as a novel treatment for insulin resistance. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to produce more insulin and suppressing glucagon https://larissairhx690394.smblogsites.com/35700731/comprehending-semaglutide-a-comprehensive-guide